Brain Inflammation, Degeneration, and Plasticity in Multiple Sclerosis

Brain Mapping: An Encyclopedic Reference

Volumn 3, Issue , 2015, Pages 917-927

  Granziera, C ^a,b   Sprenger, T ^c  

^a UNIVERSITY OF LAUSANNE   (Switzerland)

^b EPFL   (Switzerland)

^c UNIVERSITY HOSPITAL BASEL   (Switzerland)

Author keywords

[No Author keywords available]

Indexed keywords

EID: 84943329165     PISSN: None     EISSN: None     Source Type: Book    
DOI: 10.1016/B978-0-12-397025-1.00109-3     Document Type: Chapter

References (113)

1. Geurts, M., et al. Filippi, M., Gallo, P., (2010). Cortical lesions in multiple sclerosis. Nature Reviews Neurology, 6, 438-444.
2. Abou Zeid, N., Pirko, I., Erickson, B., Weigand, S. D., Thomsen, K. M., Scheithauer, B., et al. (2012). Diffusion-weighted imaging characteristics of biopsy-proven demyelinating brain lesions. Neurology, 78, 1655-1662.
3. Audoin, B., Ibarrola, D., Ranjeva, J. P., Confort-Gouny, S., Malikova, I., Ali-Cherif, A., et al. (2003). Compensatory cortical activation observed by fMRI during a cognitive task at the earliest stage of MS. Human Brain Mapping, 20, 51-58.
4. Balashov, K. E., Aung, L. L., Dhib-Jalbut, S., & Keller, I. A. (2011). Acute multiple sclerosis lesion: Conversion of restricted diffusion due to vasogenic edema. Journal of Neuroimaging, 21, 202-204.
5. Bammer, R., Augustin, M., Strasser-Fuchs, S., Seifert, T., Kapeller, P., Stollberger, R., et al. (2000). Magnetic resonance diffusion tensor imaging for characterizing diffuse and focal white matter abnormalities in multiple sclerosis. Magnetic Resonance in Medicine, 44, 583-591.
6. Banati, R. B., Newcombe, J., Gunn, R. N., Cagnin, A., Turkheimer, F., Heppner, F., et al. (2000). The peripheral benzodiazepine binding site in the brain in multiple sclerosis: Quantitative in vivo imaging of microglia as a measure of disease activity. Brain, 123(Pt 11), 2321-2337.
7. Batista, S., Zivadinov, R., Hoogs, M., Bergsland, N., Heininen-Brown, M., Dwyer, M. G., et al. (2012). Basal ganglia, thalamus and neocortical atrophy predicting slowed cognitive processing in multiple sclerosis. Journal of Neurology, 259, 139-146.
8. Behrens, T. E., & Sporns, O. (2012). Human connectomics. Current Opinion in Neurobiology, 22, 144-153.
9. Bitsch, A., Kuhlmann, T., Stadelmann, C., Lassmann, H., Lucchinetti, C., & Bruck, W. (2001). A longitudinal MRI study of histopathologically defined hypointense multiple sclerosis lesions. Annals of Neurology, 49, 793-796.
10. Bonavita, S., Gallo, A., Sacco, R., Corte, M. D., Bisecco, A., Docimo, R., et al. (2011). Distributed changes in default-mode resting-state connectivity in multiple sclerosis. Multiple Sclerosis, 17, 411-422.
11. Calabrese, M., Rinaldi, F., Grossi, P., & Gallo, P. (2011). Cortical pathology and cognitive impairment in multiple sclerosis. Expert Review of Neurotherapeutics, 11, 425-432.
12. Calabrese, M., Rinaldi, F., Mattisi, I., Bernardi, V., Favaretto, A., Perini, P., et al. (2011). The predictive value of gray matter atrophy in clinically isolated syndromes. Neurology, 77, 257-263.
13. Campbell, Z., Sahm, D., Donohue, K., Jamison, J., Davis, M., Pellicano, C., et al. (2012). Characterizing contrast-enhancing and re-enhancing lesions in multiple sclerosis. Neurology, 78, 1493-1499.
14. Castriota-Scanderbeg, A., Fasano, F., Hagberg, G., Nocentini, U., Filippi, M., & Caltagirone, C. (2003). Coefficient D(av) is more sensitive than fractional anisotropy in monitoring progression of irreversible tissue damage in focal nonactive multiple sclerosis lesions. American Journal of Neuroradiology, 24, 663-670.
15. Ceccarelli, A., Rocca, M. A., Falini, A., Tortorella, P., Pagani, E., Rodegher, M., et al. (2007). Normal-appearing white and grey matter damage in MS. A volumetric and diffusion tensor MRI study at 3.0 Tesla. Journal of Neurology, 254, 513-518.
16. Cercignani, M., Bozzali, M., Iannucci, G., Comi, G., & Filippi, M. (2001). Magnetisation transfer ratio and mean diffusivity of normal appearing white and grey matter from patients with multiple sclerosis. Journal of Neurology, Neurosurgery and Psychiatry, 70, 311-317.
17. Chavhan, G. B., Babyn, P. S., Thomas, B., Shroff, M. M., & Haacke, E. M. (2009). Principles, techniques, and applications of T2.*-based MR imaging and its special applications. Radiographics, 29, 1433-1449.
18. Chiaravalloti, N., Hillary, F., Ricker, J., Christodoulou, C., Kalnin, A., Liu, W. C., et al. (2005). Cerebral activation patterns during working memory performance in multiple sclerosis using FMRI. Journal of Clinical and Experimental Neuropsychology, 27, 33-54.
19. Ciccarelli, O., Toosy, A. T., Hickman, S. J., Parker, G. J., Wheeler-Kingshott, C. A., Miller, D. H., et al. (2005). Optic radiation changes after optic neuritis detected by tractography-based group mapping. Human Brain Mapping, 25, 308-316.
20. Ciccarelli, O., Werring, D. J., Wheeler-Kingshott, C. A., Barker, G. J., Parker, G. J., Thompson, A. J., et al. (2001). Investigation of MS normal-appearing brain using diffusion tensor MRI with clinical correlations. Neurology, 56, 926-933.
21. Davies, G. R., Altmann, D. R., Hadjiprocopis, A., Rashid, W., Chard, D. T., Griffin, C. M., et al. (2005). Increasing normal-appearing grey and white matter magnetisation transfer ratio abnormality in early relapsing-remitting multiple sclerosis. Journal of Neurology, 252, 1037-1044.
22. Davies, G. R., Hadjiprocopis, A., Altmann, D. R., Chard, D. T., Griffin, C. M., Rashid, W., et al. (2007). Normal-appearing grey and white matter T1 abnormality in early relapsing-remitting multiple sclerosis: A longitudinal study. Multiple Sclerosis, 13, 169-177.
23. De Groot, C. J., Bergers, E., Kamphorst, W., Ravid, R., Polman, C. H., Barkhof, F., et al. (2001). Post-mortem MRI-guided sampling of multiple sclerosis brain lesions: Increased yield of active demyelinating and (p)reactive lesions. Brain, 124, 1635-1645.
24. De Stefano, N., Giorgio, A., Battaglini, M., Rovaris, M., Sormani, M. P., Barkhof, F., et al. (2010). Assessing brain atrophy rates in a large population of untreated multiple sclerosis subtypes. Neurology, 74, 1868-1876.
25. Deoni, S. C. (2011). Magnetic resonance relaxation and quantitative measurement in the brain. Methods in Molecular Biology, 711, 65-108.
26. Dousset, V., Brochet, B., Deloire, M. S., Lagoarde, L., Barroso, B., Caille, J. M., et al. (2006). MR imaging of relapsing multiple sclerosis patients using ultra-smallparticle iron oxide and compared with gadolinium. American Journal of Neuroradiology, 27, 1000-1005.
27. Droogan, A. G., Clark, C. A., Werring, D. J., Barker, G. J., McDonald, W. I., & Miller, D. H. (1999). Comparison of multiple sclerosis clinical subgroups using navigated spin echo diffusion-weighted imaging. Magnetic Resonance Imaging, 17, 653-661.
28. Eissa, A., Lebel, R. M., Korzan, J. R., Zavodni, A. E., Warren, K. G., Catz, I., et al. (2009). Detecting lesions in multiple sclerosis at 4.7 tesla using phase susceptibilityweighting and T2-weighting. Journal of Magnetic Resonance Imaging, 30, 737-742.
29. Evangelou, N., Konz, D., Esiri, M. M., Smith, S., Palace, J., & Matthews, P. M. (2000). Regional axonal loss in the corpus callosum correlates with cerebral white matter lesion volume and distribution in multiple sclerosis. Brain, 123(Pt 9), 1845-1849.
30. Faivre, A., Rico, A., Zaaraoui, W., Crespy, L., Reuter, F., Wybrecht, D., et al. (2012). Assessing brain connectivity at rest is clinically relevant in early multiple sclerosis. Multiple Sclerosis, 18, 1251-1258.
31. Filippi, M., Cercignani, M., Inglese, M., Horsfield, M. A., & Comi, G. (2001). Diffusion tensor magnetic resonance imaging in multiple sclerosis. Neurology, 56, 304-311.
32. Filippi, M., & Grossman, R. I. (2002). MRI techniques to monitor MS evolution: The present and the future. Neurology, 58, 1147-1153.
33. Filippi, M., Rocca, M. A., Martino, G., Horsfield, M. A., & Comi, G. (1998). Magnetization transfer changes in the normal appearing white matter precede the appearance of enhancing lesions in patients with multiple sclerosis. Annals of Neurology, 43, 809-814.
34. Gawne-Cain, M. L., O'Riordan, J. I., Coles, A., Newell, B., Thompson, A. J., & Miller, D. H. (1998). MRI lesion volume measurement in multiple sclerosis and its correlation with disability: A comparison of fast fluid attenuated inversion recovery (fFLAIR) and spin echo sequences. Journal of Neurology, Neurosurgery and Psychiatry, 64, 197-203.
35. Ge, Y., Jensen, J. H., Lu, H., Helpern, J. A., Miles, L., Inglese, M., et al. (2007). Quantitative assessment of iron accumulation in the deep gray matter of multiple sclerosis by magnetic field correlation imaging. American Journal of Neuroradiology, 28, 1639-1644.
36. Geurts, J. J., Pouwels, P. J., Uitdehaag, B. M., Polman, C. H., Barkhof, F., & Castelijns, J. A. (2005). Intracortical lesions in multiple sclerosis: Improved detection with 3D double inversion-recovery MR imaging. Radiology, 236, 254-260.
37. Goodkin, D. E., Rooney, W. D., Sloan, R., Bacchetti, P., Gee, L., Vermathen, M., et al. (1998). A serial study of new MS lesions and the white matter from which they arise. Neurology, 51, 1689-1697.
38. Grenier, D., Pelletier, D., Normandeau, M., Newitt, D., Nelson, S., Goodkin, D. E., et al. (2002). T2 relaxation time histograms in multiple sclerosis. Magnetic Resonance Imaging, 20, 733-741.
39. Griffin, C. M., Dehmeshki, J., Chard, D. T., Parker, G. J., Barker, G. J., Thompson, A. J., et al. (2002). T1 histograms of normal-appearing brain tissue are abnormal in early relapsing-remitting multiple sclerosis. Multiple Sclerosis, 8, 211-216.
40. Haacke, E. M., Makki, M., Ge, Y., Maheshwari, M., Sehgal, V., Hu, J., et al. (2009). Characterizing iron deposition in multiple sclerosis lesions using susceptibility weighted imaging. Journal of Magnetic Resonance Imaging, 29, 537-544.
41. Hagemeier, J., Heininen-Brown, M., Poloni, G. U., Bergsland, N., Magnano, C. R., Durfee, J., et al. (2012). Iron deposition in multiple sclerosis lesions measured by susceptibility-weighted imaging filtered phase: A case control study. Journal of Magnetic Resonance Imaging, 36, 73-83.
42. Hammond, K. E., Metcalf, M., Carvajal, L., Okuda, D. T., Srinivasan, R., Vigneron, D., et al. (2008). Quantitative in vivo magnetic resonance imaging of multiple sclerosis at 7 Tesla with sensitivity to iron. Annals of Neurology, 64, 707-713.
43. Harrison, D. M., Shiee, N., Bazin, P. L., Newsome, S. D., Ratchford, J. N., Pham, D., et al. (2013). Tract-specific quantitative MRI better correlates with disability than conventional MRI in multiple sclerosis. Journal of Neurology, 260, 397-406.
44. Hauser, S. L., & Oksenberg, J. R. (2006). The neurobiology of multiple sclerosis: Genes, inflammation, and neurodegeneration. Neuron, 52, 61-76.
45. Hawellek, D. J., Hipp, J. F., Lewis, C. M., Corbetta, M., & Engel, A. K. (2011). Increased functional connectivity indicates the severity of cognitive impairment in multiple sclerosis. Proceedings of the National Academy of Sciences of the United States of America, 108, 19066-19071.
46. He, X., & Yablonskiy, D. A. (2009). Biophysical mechanisms of phase contrast in gradient echo MRI. Proceedings of the National Academy of Sciences of the United States of America, 106, 13558-13563.
47. Herzog, H. (2012). PET/MRI: Challenges, solutions and perspectives. Zeitschrift für Medizinische Physik, 22, 281-298.
48. Hess, C. P., & Mukherjee, P. (2007). Visualizing white matter pathways in the living human brain: Diffusion tensor imaging and beyond. Neuroimaging Clinics of North America, 17, 407-426, vii.
49. Hulst, H. E., Steenwijk, M. D., Versteeg, A., Pouwels, P. J., Vrenken, H., Uitdehaag, B. M., et al. (2013). Cognitive impairment in MS: Impact of white matter integrity, gray matter volume, and lesions. Neurology, 80, 1025-1032.
50. Johansen-Berg, H., & Rushworth, M. F. (2009). Using diffusion imaging to study human connectional anatomy. Annual Review of Neuroscience, 32, 75-94.
51. Kappos, L., Moeri, D., Radue, E. W., Schoetzau, A., Schweikert, K., Barkhof, F., et al. (1999). Predictive value of gadolinium-enhanced magnetic resonance imaging for relapse rate and changes in disability or impairment in multiple sclerosis: A metaanalysis. Gadolinium MRI Meta-analysis Group. Lancet, 353, 964-969.
52. Khalil, M., Enzinger, C., Langkammer, C., Tscherner, M., Wallner-Blazek, M., Jehna, M., et al. (2009). Quantitative assessment of brain iron by R(2).*relaxometry in patients with clinically isolated syndrome and relapsing-remitting multiple sclerosis. Multiple Sclerosis, 15, 1048-1054.
53. Larsson, H. B., Barker, G. J., & MacKay, A. (1998). Nuclear magnetic resonance relaxation in multiple sclerosis. Journal of Neurology, Neurosurgery and Psychiatry, 64(Suppl 1), S70-S76.
54. Larsson, H. B., Frederiksen, J., Kjaer, L., Henriksen, O., & Olesen, J. (1988). In vivo determination of T1 and T2 in the brain of patients with severe but stable multiple sclerosis. Magnetic Resonance in Medicine, 7, 43-55.
55. Larsson, H. B., Frederiksen, J., Petersen, J., Nordenbo, A., Zeeberg, I., Henriksen, O., et al. (1989). Assessment of demyelination, edema, and gliosis by in vivo determination of T1 and T2 in the brain of patients with acute attack of multiple sclerosis. Magnetic Resonance in Medicine, 11, 337-348.
56. Lee, M., Reddy, H., Johansen-Berg, H., Pendlebury, S., Jenkinson, M., Smith, S., et al. (2000). The motor cortex shows adaptive functional changes to brain injury from multiple sclerosis. Annals of Neurology, 47, 606-613.
57. Li, D. K., Held, U., Petkau, J., Daumer, M., Barkhof, F., Fazekas, F., et al. (2006). MRI T2 lesion burden in multiple sclerosis: A plateauing relationship with clinical disability. Neurology, 66, 1384-1389.
58. Li, Y., Jewells, V., Kim, M., Chen, Y., Moon, A., Armao, D., et al. (2012). Diffusion tensor imaging based network analysis detects alterations of neuroconnectivity in patients with clinically early relapsing-remitting multiple sclerosis. Human Brain Mapping.
59. Loitfelder, M., Filippi, M., Rocca, M., Valsasina, P., Ropele, S., Jehna, M., et al. (2012). Abnormalities of resting state functional connectivity are related to sustained attention deficits in MS. PLoS One, 7, e42862.
60. MacKay, A. L., Vavasour, I. M., Rauscher, A., Kolind, S. H., Madler, B., Moore, G. R., et al. (2009). MR relaxation in multiple sclerosis. Neuroimaging Clinics of North America, 19, 1-26.
61. Mainero, C., Caramia, F., Pozzilli, C., Pisani, A., Pestalozza, I., Borriello, G., et al. (2004). fMRI evidence of brain reorganization during attention and memory tasks in multiple sclerosis. NeuroImage, 21, 858-867.
62. Manfredonia, F., Ciccarelli, O., Khaleeli, Z., Tozer, D. J., Sastre-Garriga, J., Miller, D. H., et al. (2007). Normal-appearing brain T1 relaxation time predicts disability in early primary progressive multiple sclerosis. Archives of Neurology, 64, 411-415.
63. Moll, N. M., Rietsch, A. M., Thomas, S., Ransohoff, A. J., Lee, J. C., Fox, R., et al. (2011). Multiple sclerosis normal-appearing white matter: Pathology-imaging correlations. Annals of Neurology, 70, 764-773.
64. Ormerod, I. E. (1986). Origin of abnormal magnetic resonance imaging signal in multiple sclerosis. Lancet, 2, 338.
65. Ormerod, I. E., Bronstein, A., Rudge, P., Johnson, G., Macmanus, D., Halliday, A. M., et al. (1986). Magnetic resonance imaging in clinically isolated lesions of the brain stem. Journal of Neurology, Neurosurgery and Psychiatry, 49, 737-743.
66. Pantano, P., Iannetti, G. D., Caramia, F., Mainero, C., Di Legge, S., Bozzao, L., et al. (2002). Cortical motor reorganization after a single clinical attack of multiple sclerosis. Brain, 125, 1607-1615.
67. Pantano, P., Mainero, C., & Caramia, F. (2006). Functional brain reorganization in multiple sclerosis: Evidence from fMRI studies. Journal of Neuroimaging, 16, 104-114.
68. Papadopoulou, A., Von Felten, S., Traud, S., Rahman, A., Quan, J., King, R., et al. (2012). Evolution of MS lesions to black holes under DNA vaccine treatment. Journal of Neurology, 259, 1375-1382.
69. Parry, A., Clare, S., Jenkinson, M., Smith, S., Palace, J., & Matthews, P. M. (2002). White matter and lesion T1 relaxation times increase in parallel and correlate with disability in multiple sclerosis. Journal of Neurology, 249, 1279-1286.
70. Penner, I. K., Kappos, L., Rausch, M., Opwis, K., & Radu, E. W. (2006). Therapyinduced plasticity of cognitive functions in MS patients: Insights from fMRI. Journal of Physiology-Paris, 99, 455-462.
71. Penner, I. K., Opwis, K., & Kappos, L. (2007). Relation between functional brain imaging, cognitive impairment and cognitive rehabilitation in patients with multiple sclerosis. Journal of Neurology, 254(Suppl 2), II53-II57.
72. Perez-Miralles, F., Sastre-Garriga, J., Tintore, M., Arrambide, G., Nos, C., Perkal, H., et al. (2013). Clinical impact of early brain atrophy in clinically isolated syndromes. Multiple Sclerosis, 19(14), 1878-1886.
73. Polman, C. H., Reingold, S. C., Banwell, B., Clanet, M., Cohen, J. A., Filippi, M., et al. (2011). Diagnostic criteria for multiple sclerosis: 2010 revisions to the McDonald criteria. Annals of Neurology, 69, 292-302.
74. Poonawalla, A. H., Hasan, K. M., Gupta, R. K., Ahn, C. W., Nelson, F., Wolinsky, J. S., et al. (2008). Diffusion-tensor MR imaging of cortical lesions in multiple sclerosis: Initial findings. Radiology, 246, 880-886.
75. Popescu, B. F., Pirko, I., & Lucchinetti, C. F. (2013). Pathology of multiple sclerosis: Where do we stand? Continuum, 19, 901-921.
76. Preziosa, P., Rocca, M. A., Mesaros, S., Pagani, E., Stosic-Opincal, T., Kacar, K., et al. (2011). Intrinsic damage to the major white matter tracts in patients with different clinical phenotypes of multiple sclerosis: A voxelwise diffusion-tensor MR study. Radiology, 260, 541-550.
77. Reddy, H., Narayanan, S., Arnoutelis, R., Jenkinson, M., Antel, J., Matthews, P. M., et al. (2000). Evidence for adaptive functional changes in the cerebral cortex with axonal injury from multiple sclerosis. Brain, 123(Pt 11), 2314-2320.
78. Reich, D. S., Smith, S. A., Zackowski, K. M., Gordon-Lipkin, E. M., Jones, C. K., Farrell, J. A., et al. (2007). Multiparametric magnetic resonance imaging analysis of the corticospinal tract in multiple sclerosis. NeuroImage, 38, 271-279.
79. Rocca, M. A., Agosta, F., Sormani, M. P., Fernando, K., Tintore, M., Korteweg, T., et al. (2008). A three-year, multi-parametric MRI study in patients at presentation with CIS. Journal of Neurology, 255, 683-691.
80. Rocca, M. A., Falini, A., Colombo, B., Scotti, G., Comi, G., & Filippi, M. (2002). Adaptive functional changes in the cerebral cortex of patients with nondisabling multiple sclerosis correlate with the extent of brain structural damage. Annals of Neurology, 51, 330-339.
81. Rocca, M. A., & Filippi, M. (2007). Functional MRI in multiple sclerosis. Journal of Neuroimaging, 17(Suppl 1), 36S-41S.
82. Rocca, M. A., Mesaros, S., Preziosa, P., Pagani, E., Stosic-Opincal, T., Dujmovic-Basuroski, I., et al. (2013). Wallerian and trans-synaptic degeneration contribute to optic radiation damage in multiple sclerosis: A diffusion tensor MRI study. Multiple Sclerosis, 19(12), 1610-1617.
83. Rocca, M. A., Valsasina, P., Martinelli, V., Misci, P., Falini, A., Comi, G., et al. (2012). Large-scale neuronal network dysfunction in relapsing-remitting multiple sclerosis. Neurology, 79, 1449-1457.
84. Rovaris, M., Bozzali, M., Iannucci, G., Ghezzi, A., Caputo, D., Montanari, E., et al. (2002). Assessment of normal-appearing white and gray matter in patients with primary progressive multiple sclerosis: A diffusion-tensor magnetic resonance imaging study. Archives of Neurology, 59, 1406-1412.
85. Rovira, A., & Alonso, J. (2013). (1)H magnetic resonance spectroscopy in multiple sclerosis and related disorders. Neuroimaging Clinics of North America, 23, 459-474.
86. Sahraian, M. A., & Radue, E. W. (2007). MS lesions in T2-weighted Images. In A. Sahraian & E. W. Radue (Eds.), MRI Atlas of MS Lesions. Berlin: Springer.
87. Sanfilipo, M. P., Benedict, R. H., Sharma, J., Weinstock-Guttman, B., & Bakshi, R. (2005). The relationship between whole brain volume and disability in multiple sclerosis: A comparison of normalized gray vs. white matter with misclassification correction. NeuroImage, 26, 1068-1077.
88. Sbardella, E., Petsas, N., Tona, F., Prosperini, L., Raz, E., Pace, G., et al. (2013). Assessing the correlation between grey and white matter damage with motor and cognitive impairment in multiple sclerosis patients. PLoS One, 8, e63250.
89. Sbardella, E., Tona, F., Petsas, N., & Pantano, P. (2013). DTI measurements in multiple sclerosis: Evaluation of brain damage and clinical implications. Multiple Sclerosis International, 2013, 671730.
90. Schmierer, K., Tozer, D. J., Scaravilli, F., Altmann, D. R., Barker, G. J., Tofts, P. S., et al. (2007). Quantitative magnetization transfer imaging in postmortem multiple sclerosis brain. Journal of Magnetic Resonance Imaging, 26, 41-51.
91. Schmierer, K., Wheeler-Kingshott, C. A., Boulby, P. A., Scaravilli, F., Altmann, D. R., Barker, G. J., et al. (2007). Diffusion tensor imaging of post mortem multiple sclerosis brain. NeuroImage, 35, 467-477.
92. Shu, N., Liu, Y., Li, K., Duan, Y., Wang, J., Yu, C., et al. (2011). Diffusion tensor tractography reveals disrupted topological efficiency in white matter structural networks in multiple sclerosis. Cerebral Cortex, 21, 2565-2577.
93. Simon, J. H., Zhang, S., Laidlaw, D. H., Miller, D. E., Brown, M., Corboy, J., et al. (2006). Identification of fibers at risk for degeneration by diffusion tractography in patients at high risk for MS after a clinically isolated syndrome. Journal of Magnetic Resonance Imaging, 24, 983-988.
94. Staffen, W., Mair, A., Zauner, H., Unterrainer, J., Niederhofer, H., Kutzelnigg, A., et al. (2002). Cognitive function and fMRI in patients with multiple sclerosis: Evidence for compensatory cortical activation during an attention task. Brain, 125, 1275-1282.
95. Suzuki, M., Kudo, K., Sasaki, M., Takahashi, S., Takahashi, J., Fujima, N., et al. (2011). Detection of active plaques in multiple sclerosis using susceptibility-weighted imaging: Comparison with gadolinium-enhanced MR imaging. Magnetic Resonance in Medical Sciences, 10, 185-192.
96. Takano, A., Piehl, F., Hillert, J., Varrone, A., Nag, S., Gulyas, B., et al. (2013). In vivo TSPO imaging in patients with multiple sclerosis: A brain PET study with [18 F] FEDAA1106. EJNMMI Research, 3, 30.
97. Tardif, C. L., Bedell, B. J., Eskildsen, S. F., Collins, D. L., & Pike, G. B. (2012). Quantitative magnetic resonance imaging of cortical multiple sclerosis pathology. Multiple Sclerosis International, 2012, 742018.
98. Tomassini, V., Johansen-Berg, H., Jbabdi, S., Wise, R. G., Pozzilli, C., Palace, J., et al. (2012). Relating brain damage to brain plasticity in patients with multiple sclerosis. Neurorehabilitation and Neural Repair, 26, 581-593.
99. Uhlenbrock, D., & Sehlen, S. (1989). The value of T1-weighted images in the differentiation between MS, white matter lesions, and subcortical arteriosclerotic encephalopathy (SAE). Neuroradiology, 31, 203-212.
100. Van, A. T., Granziera, C., & Bammer, R. (2010). An introduction to model-independent diffusion magnetic resonance imaging. Topics in Magnetic Resonance Imaging, 21, 339-354.
101. Van Waesberghe, J. H., Van Walderveen, M. A., Castelijns, J. A., Scheltens, P., Lycklama Á Nijeholt, G. J., Polman, C. H., et al. (1998). Patterns of lesion development in multiple sclerosis: Longitudinal observations with T1-weighted spin-echo and magnetization transfer MR. American Journal of Neuroradiology, 19, 675-683.
102. Van Walderveen, M. A., Van Schijndel, R. A., Pouwels, P. J., Polman, C. H., & Barkhof, F. (2003). Multislice T1 relaxation time measurements in the brain using IR-EPI: Reproducibility, normal values, and histogram analysis in patients with multiple sclerosis. Journal of Magnetic Resonance Imaging, 18, 656-664.
103. Vellinga, M. M., Oude Engberink, R. D., Seewann, A., Pouwels, P. J., Wattjes, M. P., Van Der Pol, S. M., et al. (2008). Pluriformity of inflammation in multiple sclerosis shown by ultra-small iron oxide particle enhancement. Brain, 131, 800-807.
104. Vellinga, M. M., Vrenken, H., Hulst, H. E., Polman, C. H., Uitdehaag, B. M., Pouwels, P. J., et al. (2009). Use of ultrasmall superparamagnetic particles of iron oxide (USPIO)-enhanced MRI to demonstrate diffuse inflammation in the normalappearing white matter (NAWM) of multiple sclerosis (MS) patients: An exploratory study. Journal of Magnetic Resonance Imaging, 29, 774-779.
105. Vowinckel, E., Reutens, D., Becher, B., Verge, G., Evans, A., Owens, T., et al. (1997). PK11195 binding to the peripheral benzodiazepine receptor as a marker of microglia activation in multiple sclerosis and experimental autoimmune encephalomyelitis. Journal of Neuroscience Research, 50, 345-353.
106. Vrenken, H., Geurts, J. J., Knol, D. L., Van Dijk, L. N., Dattola, V., Jasperse, B., et al. (2006). Whole-brain T1 mapping in multiple sclerosis: Global changes of normalappearing gray and white matter. Radiology, 240, 811-820.
107. Vrenken, H., Pouwels, P. J., Geurts, J. J., Knol, D. L., Polman, C. H., Barkhof, F., et al. (2006). Altered diffusion tensor in multiple sclerosis normal-appearing brain tissue: Cortical diffusion changes seem related to clinical deterioration. Journal of Magnetic Resonance Imaging, 23, 628-636.
108. Wedeen, V. J., Hagmann, P., Tseng, W. Y., Reese, T. G., & Weisskoff, R. M. (2005). Mapping complex tissue architecture with diffusion spectrum magnetic resonance imaging. Magnetic Resonance in Medicine, 54, 1377-1386.
109. Werring, D. J., Brassat, D., Droogan, A. G., Clark, C. A., Symms, M. R., Barker, G. J., et al. (2000). The pathogenesis of lesions and normal-appearing white matter changes in multiple sclerosis: A serial diffusion MRI study. Brain, 123(Pt 8), 1667-1676.
110. Whittall, K. P., MacKay, A. L., Li, D. K., Vavasour, I. M., Jones, C. K., & Paty, D. W. (2002). Normal-appearing white matter in multiple sclerosis has heterogeneous, diffusely prolonged T(2). Magnetic Resonance in Medicine, 47, 403-408.
111. Wiggermann, V., Hernandez Torres, E., Vavasour, I. M., Moore, G. R., Laule, C., MacKay, A. L., et al. (2013). Magnetic resonance frequency shifts during acute MS lesion formation. Neurology, 81, 211-218.
112. Zatorre, R. J., Fields, R. D., & Johansen-Berg, H. (2012). Plasticity in gray and white: Neuroimaging changes in brain structure during learning. Nature Neuroscience, 15, 528-536.
113. Zhao, G. J., Koopmans, R. A., Li, D. K., Bedell, L., & Paty, D. W. (2000). Effect of interferon beta-1b in MS: Assessment of annual accumulation of PD/T2 activity on MRI. UBC MS/MRI Analysis Group and the MS Study Group. Neurology, 54, 200-206.